Overall survival among chemotherapy-naïve castration-resistant prostate cancer patients under abiraterone versus enzalutamide: a direct comparison based on a 2014-2018 French population study (the SPEAR cohort).
Scailteux, Lucie-Marie, Campillo-Gimenez, Boris, Kerbrat, Sandrine, Despas, Fabien, Mathieu, Romain, Vincendeau, Sébastien, Balusson, Frédéric, Happe, André, Nowak, Emmanuel, Oger, EmmanuelJournal:
American Journal of Epidemiology
DOI:
10.1093/aje/kwaa190
Date:
September, 2020
File:
PDF, 787 KB
2020